Tumor Growth Rate as a Metric of Progression, Response, and Prognosis in Pancreatic and Intestinal Neuroendocrine Tumors

BMC Cancer - United Kingdom
doi 10.1186/s12885-018-5257-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapeutic Targeting of Tumor-Associated Macrophages in Pancreatic Neuroendocrine Tumors

International Journal of Cancer
Cancer ResearchOncology
2018English

PTPRM, a Candidate Tumor Suppressor Gene in Small Intestinal Neuroendocrine Tumors

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

Differences Between Grades G1 and G2 Hypovascular Pancreatic Neuroendocrine Tumors and Pancreatic Neuroendocrine Carcinoma

Radiology
Nuclear MedicineRadiologyImaging
2017English

Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2017English

Prognosis of Sporadic Resected Small (≤2 Cm) Nonfunctional Pancreatic Neuroendocrine Tumors – A Multi-Institutional Study

HPB
HepatologyGastroenterology
2018English

Implication of Filamin a in Pulmonary Neuroendocrine Tumors Aggressiveness and Progression

Endocrine Abstracts
2016English

Medical Treatment of Neuroendocrine Gut and Pancreatic Tumors

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

Cancers
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy